NRX PharmaceuticalsNRXP
13F holders, Q4 2024 (December 31)25holders +7
10new positions
3sold out
1famous investor
$2.20avg. 13F price*
At the end of Q4 2024, 25 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings, up 7 from Q3 2024. 10 opened new positions and 3 sold out. The largest holders were AdvisorShares Investments LLC ($683K), Vanguard Group Inc. ($529K) and Anson Funds Management LP ($408K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $334K |
| Exits | 3 | $64K |
All 13F filers, Q3 2024 → Q4 2024: 375,545 shares bought and 41,230 shares sold, net +334,315 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| AdvisorShares Investments LLC | 0.13% | Add +138.6% | 310,314 | $683K |
| Vanguard Group Inc. | 0.00% | No change | 240,316 | $529K |
| Anson Funds Management LP | 0.05% | Add +30.3% | 185,660 | $408K |
| Susquehanna International Group, LLP | 0.00% | New | 82,152 | $181K |
| Geode Capital Management, LLC | 0.00% | Reduce -4.0% | 74,251 | $163K |
| BlackRock, Inc. | 0.00% | No change | 29,075 | $64K |
| Millennium Management | 0.00% | New | 27,624 | $61K |
| Squarepoint Ops LLC | 0.00% | New | 25,299 | $56K |
| State Street Corp. | 0.00% | No change | 16,724 | $37K |
| One Wealth Management Investment & Advisory Services, LLC | 0.05% | No change | 15,041 | $33K |
| Townsquare Capital LLC | 0.00% | No change | 15,041 | $33K |
| Sassicaia Capital Advisers LLC | 0.80% | New | 15,000 | $33K |
| Morgan Stanley | 0.00% | No change | 4,396 | $10K |
| Bank of America Corp. | 0.00% | Add +0.2% | 3,298 | $7K |
| Wells Fargo & Company | 0.00% | Reduce -18.8% | 2,160 | $5K |
| Simplex Trading, LLC | 0.00% | New | 1,001 | $2K |
| Citigroup Inc. | 0.00% | New | 593 | $1K |
| FMR LLC | 0.00% | New | 150 | $330 |
| UBS Group AG | 0.00% | Add +294.7% | 150 | $330 |
| Group One Trading LLC | 0.00% | New | 99 | $218 |
| Osaic Holdings, Inc. | 0.00% | New | 90 | $198 |
| NewEdge Advisors, LLC | 0.00% | No change | 83 | $183 |
| JPMorgan Chase & Co. | 0.00% | Add +6.0% | 53 | $117 |
| Carolina Wealth Advisors, LLC | 0.00% | New | 50 | $110 |
| Larson Financial Group LLC | 0.00% | No change | 22 | $48 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.